Register
Home >> Oncology >> Hematological Malignancy Bookmark this
Practice Guidelines
American Society of Clinical Oncology, 2007
European Society for Medical Oncology, 2009
Scientific Advisors of the International Myeloma Foundation, 2008
National Comprehensive Cancer Network, 2010
European Society for Medical Oncology, 2009
More>>
Hematological Malignancy Disease Information
Chronic myelogenous leukemia (CML) is a malignant myeloproliferative disorder of hematopoietic stem cells in the bone marrow. The natural history is progression from a chronic phase with no or few symptoms that may last 3–5 years. There then follows an accelerated myeloproliferative phase...
Practice Guidelines
National Comprehensive Cancer Network, 2009
European Society for Medical Oncology, 2009
European Society for Medical Oncology, 2009
British Society for Haematology, 2005
National Comprehensive Cancer Network, 2010
More>>
Copyright @ 2010 Elsevier (Singapore) Pte Ltd. All rights reserved.